Clinical Trial Update: Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of recombinant human growth hormone in adults with growth hormone deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Recombinant human growth hormone (somatropin)

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Adult Growth Hormone Deficiency | Phase 2 | Status: COMPLETED